Table 1 Mean doses to the targets and OARs/ROI after final dose calculation for all ten patients together with the arithmetic mean doses (± standard deviation (SD)) over all patients
Pat #—right (R)/left (L) side | Mean dose to targets and OARs/ROI [Gy] | ||||||
|---|---|---|---|---|---|---|---|
PTV | TVSurface | Lung (ipsilat.) | Lung (contralat.) | Heart | Breast (contralat.) | Thyroid | |
1—L | 42.3 | 37.6 | 9.8 | 3.3 | 5.9 | 3.5 | 1.0 |
2—L | 42.2 | 37.2 | 11.0 | 4.6 | 6.8 | 5.2 | 1.3 |
3—L | 42.2 | 37.4 | 10.1 | 3.9 | 5.6 | 4.6 | 2.9 |
4—L | 42.0 | 37.1 | 9.7 | 3.4 | 6.1 | 6.4 | 1.1 |
5—R | 42.2 | 37.7 | 11.0 | 4.8 | 5.7 | 5.1 | 0.9 |
6—R | 42.2 | 36.7 | 10.1 | 3.9 | 6.5 | 5.0 | 0.9 |
7—L | 42.2 | 37.8 | 11.4 | 4.1 | 5.5 | 6.4 | 2.0 |
8—L | 42.2 | 37.2 | 11.1 | 4.1 | 7.6 | 5.4 | 1.3 |
9—L | 42.2 | 37.3 | 11.4 | 4.6 | 7.5 | 4.2 | 2.6 |
10—L | 42.3 | 37.3 | 12.0 | 4.3 | 7.6 | 4.1 | 1.3 |
Average (± SD) | 42.2 (± 0.1) | 37.3 (± 0.3) | 10.8 (± 0.8) | 4.1 (± 0.5) | 6.5 (± 0.8) | 5.0 (± 0.9) | 1.5 (± 0.7) |